Dupont Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,438
Closed -$410K 1838
2021
Q3
$410K Sell
3,438
-930
-21% -$102K 0.01% 965
2021
Q2
$425K Buy
4,368
+2,693
+161% +$240K 0.01% 1073
2021
Q1
$148K Buy
+1,675
New +$156K ﹤0.01% 1323
2020
Q4
Sell
-4,649
Closed -$528K 1407
2020
Q3
$528K Sell
4,649
-8,302
-64% -$872K 0.01% 729
2020
Q2
$1.28M Sell
12,951
-7,882
-38% -$629K 0.03% 434
2020
Q1
$1.34M Sell
20,833
-7,091
-25% -$497K 0.03% 378
2019
Q4
$1.67M Buy
27,924
+10,389
+59% +$641K 0.04% 402
2019
Q3
$1.03M Buy
17,535
+626
+4% +$40K 0.02% 512
2019
Q2
$1.09M Sell
16,909
-4,677
-22% -$302K 0.02% 520
2019
Q1
$1.37M Buy
+21,586
New +$1.13M 0.03% 457

Other funds holding TNDM

Dupont Capital Management's TNDM Position: Q4 2021 in Review

Dupont Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 3,438 shares — an estimated $410K sold.

Dupont Capital Management first reported a position in TNDM in Q1 2019 and held it in 10 quarters. The position peaked at $1.67M in Q4 2019. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

  • Dupont Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
  • Dupont Capital Management sold 3,438 Tandem Diabetes Care shares in Q4 2021, an estimated $410K.
  • Dupont Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 10 quarters.
  • Dupont Capital Management's Tandem Diabetes Care position peaked at $1.67M in Q4 2019.
  • 388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Dupont Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.